Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

OIG denies proposed manufacturer-sponsored copay support program for Medicare beneficiaries

On September 23, the HHS OIG published Advisory Opinion No. 20-05, advising that OIG found “highly suspect” a manufacturer’s proposal to create a copay subsidy program to...

News

AbbVie settlement seems to end period of intense scrutiny for manufacturer patient support programs

Earlier this month, the California Insurance Commissioner announced that AbbVie had entered into a settlement agreement with the California Department of Insurance (CDOI) to resolve...

News

CMS’ 2021 health insurance exchanges rule finalizes pharmaceutical manufacturer coupon policy shift

On May 7, 2020, the Centers for Medicare & Medicaid Services (CMS) released the 2021 Notice of Benefit and Payment Parameters final rule (“2021 NBPP Final Rule”), finalizing ...

News

HHS-OIG launches portal for COVID-19 related questions about its enforcement authorities

Today, the Office of Inspector General for the U.S. Department of Health and Human Services (HHS-OIG) announced the launch of a portal that will post announcements and information issued by ...

Insights

OIG clears manufacturer-sponsored travel and lodging support in limited circumstances
Registered Content

The latest advisory opinion published by the U.S. Department of Health and Human Services Office of the Inspector General (HHS OIG) approves one pharmaceutical manufacturer’s travel...

Hogan Lovells Publications

New False Claims Act settlement points to risks of offering free goods and services to customers and referral source Health Alert

A recent settlement announced by the U.S. Department of Justice (DOJ) strikes a note of caution for device and drug manufacturers who are considering offering free or discounted goods and...

News

HHS tackles barriers to value-based care: Part 1 – new protections for value-based arrangements under Stark and the AKS and other key AKS changes

Nearly a decade after the Affordable Care Act signaled a transition of the U.S. health care system to value-based care, the Department of Health and Human Services (HHS) published on...

Insights

Senate Finance Committee Releases Details of Drug Pricing Bill Life Sciences & Health Care Alert
Registered Content

Yesterday, the Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Oregon) released a description of The Prescription Drug Pricing Reduction Act of...

News

Trump administration proposes ambitious AKS rewrite on drug rebates, but needs answers to big questions

In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs, the Trump administration has proposed ...

Loading data